StockData
TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc. (TCRX) KPIs and segments

TCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/3089% below fair value
$0.15+0.01 (+4.07%)

Close on Nov 17, 2026Market cap $10.23MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive TScan Therapeutics's business

Coming soon

This tab will track the numbers specific to TScan Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?